NasdaqGS - Nasdaq Real Time Price USD

PetIQ, Inc. (PETQ)

Compare
30.64 -0.03 (-0.10%)
At close: September 11 at 4:00 PM EDT
Loading Chart for PETQ
DELL
  • Previous Close 30.67
  • Open 30.63
  • Bid 22.06 x 100
  • Ask 39.33 x 200
  • Day's Range 30.64 - 30.73
  • 52 Week Range 15.09 - 30.77
  • Volume 236,896
  • Avg. Volume 785,441
  • Market Cap (intraday) 915.701M
  • Beta (5Y Monthly) 1.74
  • PE Ratio (TTM) 82.81
  • EPS (TTM) 0.37
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 30.50

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

petiq.com

1,121

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PETQ

View More

Performance Overview: PETQ

Trailing total returns as of 9/11/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PETQ
55.14%
S&P 500
16.44%

1-Year Return

PETQ
74.19%
S&P 500
24.60%

3-Year Return

PETQ
10.06%
S&P 500
24.57%

5-Year Return

PETQ
10.61%
S&P 500
86.42%

Compare To: PETQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PETQ

View More

Valuation Measures

Annual
As of 9/11/2024
  • Market Cap

    908.90M

  • Enterprise Value

    1.29B

  • Trailing P/E

    82.84

  • Forward P/E

    14.62

  • PEG Ratio (5yr expected)

    1.56

  • Price/Sales (ttm)

    0.88

  • Price/Book (mrq)

    3.52

  • Enterprise Value/Revenue

    1.13

  • Enterprise Value/EBITDA

    14.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.16%

  • Return on Assets (ttm)

    4.86%

  • Return on Equity (ttm)

    5.52%

  • Revenue (ttm)

    1.13B

  • Net Income Avi to Common (ttm)

    13.19M

  • Diluted EPS (ttm)

    0.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    84.13M

  • Total Debt/Equity (mrq)

    176.93%

  • Levered Free Cash Flow (ttm)

    2.18M

Research Analysis: PETQ

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

30.00 Low
30.50 Average
30.64 Current
31.00 High
 

Company Insights: PETQ

People Also Watch